×
Organon Long Term Debt 2019-2024 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organon long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Organon Long Term Debt 2019-2024 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organon long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$91.4B
Cencora (COR)
$47.5B
DiDi Global (DIDIY)
$23.3B
Natera (NTRA)
$21.4B
ICON (ICLR)
$16.1B
Viatris (VTRS)
$15.6B
Avantor (AVTR)
$13.4B
Revvity (RVTY)
$13.4B
CochLear (CHEOY)
$12.8B
BioMerieux (BMXMF)
$12.7B
Solventum (SOLV)
$11.6B
Medpace Holdings (MEDP)
$9.8B
Doximity (DOCS)
$9.6B
Charles River Laboratories (CRL)
$9.5B
HealthEquity (HQY)
$9B
Sonic Healthcare (SKHHY)
$8.8B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Sotera Health (SHC)
$3.9B
BrightSpring Health Services (BTSG)
$3.2B
Surgery Partners (SGRY)
$2.9B
PACS (PACS)
$2.6B
Concentras Parent (CON)
$2.6B
Ardent Health Partners (ARDT)
$2.4B
Premier (PINC)
$2.1B
Alignment Healthcare (ALHC)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GeneDx Holdings (WGS)
$2B
GoodRx Holdings (GDRX)
$1.6B
Teladoc Health (TDOC)
$1.5B